Introduction
The rapid dissemination of extended-spectrum beta-lactamase (ESBL)-producing bacteria has led to the increased utilization of carbapenems as antimicrobials of last resort for the treatment of infections caused by these multidrug resistant (MDR) microorganisms [1] . Thus in recent years, carbapenem-resistant Enterobacteriaceae (CRE) harbouring resistance genes for carbapenemases have emerged as major causes of nosocomial infections globally [2] [3] . Among isolates reported to the National Healthcare Safety Network (NHSN) in 2009 and 2010, carbapenem resistance was reported in up to 77.2% of Escherichia coli and Klebsiella pneumoniae [4] . Clinically signifi cant carbapenmases in Enterobacteriaceae, are the Ambler molecular Class A (KPC), Class B (VIM, IMP, NDM) and Class D (OXA-48) types [5] . Infections caused by CRE harbouring these resistance genes have limited treatment options, spread easily in healthcare settings and are associated with high mortality [2, [6] [7] .
To date, there is a paucity of data on the prevalence of CRE isolates in the Kingdom of Saudi Arabia. Two recently published studies indicate that CRE isolates positive for bla NDM-1 and bla are circulating in hospitals in Riyadh, Saudi Arabia [8] [9] . This study aimed to determine the prevalence of carbapenem resistance as well as evaluate molecular and phenotypic methods for the detection and characterization of CRE isolates at a large tertiary care hospital in Saudi Arabia.
Materials and Methods

Clinical specimens, bacterial isolates and their identifi cation
This study was carried out between January 2011 and September 2013 at the King Khalid University Hospital, Riyadh Saudi Arabia. All ESBL-positive isolates identifi ed from routine investigation in the bacteriology laboratory dur-ing the study period were included in the study. The isolates were obtained from specimens submitted for routine bacteriology investigations. These specimens were blood, wound swabs, endotracheal secretions, sputum, body fl uids and urine. Isolates were stored at -80 °C for further analysis. Identifi cation of organism and antimicrobial susceptibility testing were carried out by the MicroScan Walkaway 96 plus System (Siemen Healthcare Diagnostic Inc.). ESBL screening was carried out by both double disk and E-test according to the Clinical and Laboratory Standards Institute (CLSI), 2013 recommended guidelines [10] . Only the fi rst representative isolate per patient was included and all other repeat isolates were excluded. Carbapenem resistant but carbapenemase-negative isolates were used as negative controls.
Antimicrobial susceptibility testing
Antibiotic susceptibility using the Kirby-Bauer method was carried out on Mueller-Hinton agar with commercially available disks from Oxoid in accordance with CLSI guidelines [10] . Antibiotics tested were amikacin (30 μg), gentamicin (10 μg), ciprofl oxacin (5 μg) and sulfamethoxazole (23.75/1.25 μg). The minimum inhibitory concentration for imipenem, meropenem, colistin and tigecycline was determined by E-test (bioMerieux, Marcy l'Etoile, France) following the manufacturer's instructions and results were interpreted as per CLSI guidelines [10] . Escherichia coli ATCC 25922 was used for the quality control. All the carbapenem resistant isolates were confi rmed by using modifi ed Hodge Test following CLSI guidelines [10] .
Phenotypic confi rmation of carbapenemase production
The MASTDISCS TM ID inhibitor combination disk method (Mast Diagnostics) for the phenotypic confi rmation of carbapenemases production was used according to the manufacturer's instructions. This methodology utilizes four disks: disk A, containing a carbapenem (meropenem, 10 μg); disk B, consisting of meropenem (10 μg) and an MBL inhibitor; disk C, consisting of meropenem (10 μg) with a KPC inhibitor; and disk D, containing meropenem (10 μg) with an AmpC inhibitor. Interpretation of the test requires comparison of the zone of inhibition of disk A with the zones of inhibition of each of disks B, C, and D. If disk B shows a zone difference of ≥5 mm from disk A this is indicative of MBL activity. Zone difference of ≥4 mm for disk C compared to disk A, indicates KPC activity. If disk C and disk D show a zone difference of ≥4 and ≥5 mm, respectively, from disk A, this is indicative of AmpC activity coupled with porin loss (impermeability) [11] .
Genotypic testing for ESBL and carbapenemases genes
This was carried out using the Check-MDR CT102 DNA microarray (CheckPoints BV, Wageningen, Netherlands) at the Antimicrobial Resistance Research Laboratory, Alfaisal University, Riyadh Saudi Arabia. At the time of the genotypic testing, the research laboratory was blinded to the fi ndings of the phenotypic assays. The Check-MDR CT102 combines ligation-mediated amplifi cation with detection of amplifi ed products on a microarray to detect carbapenemase genes (bla OXA-48 , bla NDM , bla IMP , bla VIM and bla KPC ), bla CTX-M groups (bla CTX-M groups 1, 2 and 9, or combined 8/25), and common ESBLassociated single nucleotide polymorphisms in bla TEM and bla SHV variants [12] . Whole-cell DNAs were extracted from overnight bacterial cultures using the Mo Bio UltraClean™ Microbial DNA Isolation Kit. Microarray assays were performed according to the manufacturer's instructions with provided tubes and reagents as previously described [12] [13] .
Determination of clonal relationship
This was carried out using the DiversiLab repetitive extragenic palindromic PCR (rep-PCR) system (bioMérieux). This was carried out only for K. pneumoniae which constituted the bulk of our isolates. Briefl y, genomic DNA extraction and preparation was carried out using the Mo Bio UltraClean™ Microbial DNA Isolation Kit. As previously described, the rep-PCR amplifi cation was performed using the DiversiLab Klebsiella fi ngerprinting kit and detection done using the microfl uidic LabChip kits on Agilent 2100 bioanalyzer according to the manufacturer's instructions (bioMérieux) [14] . The amplifi ed rep-PCR DNA fragment patterns were analyzed with the DiversiLab analysis software using the modifi ed Kullback-Leibler statistical method.
Results
A 883 ESBL-positive Enterobacteriaceae were detected during this period. A total of 14 isolates suspected to have carbapenemase enzymes were identi- Tables Ia and  Ib show the clinical characteristics of the patients from whom these isolates were obtained and the antibiogram of the isolates. The fi ndings of the genotypic testing using the Check-MDR CT102 DNA microarray for the 14 isolates are shown in Table II . Twelve isolates were positive for ESBL genes of which there were 10bla CTX-M , 6bla TEM and 9bla SHV . Eight isolates were positive for more than one ESBL gene (Table II) . Of the 10bla CTX-M positive isolates, 7 haboured only bla CTX-M1 , 2 had only bla CTX-M9 , while one isolate harboured both bla CTX-M1 and bla CTX-M9 . Ten isolates were positive for carbapenemase genes of which 5 were bla NDM-1 , 3bla OXA-48 and 3bla VIM-1 . One isolate was positive for both bla and bla VIM-1 . Nine isolates were positive for both ESBL and carbapenemase genes (Table II) . All isolates were negative for bla KPC , bla IMP and bla VIM-2. Comparison of genotypic and phenotypic testing for carbapenemase producers revealed that bla VIM-1 positive isolates were detected as NDM-1 on phenotypic testing (Table III) . All isolates which were negative for carbapenemase genes were also negative for NDM-1 by phenotypic testing. Isolates positive for only bla OXA-48 were reported as negative on phenotypic testing (Table III) . Both phenotypic and genotypic methods were in agreement in the identifi cation of 2 carbapenem resistant isolates which were negative for carbapenemase genes (Table III) . The correlation between phenotypic and genotypic tests is show in Table IV . Two K. pneumoniae isolates (6a and 6b) were from a single patient. These two isolates showed different antibiogram patterns (Table Ib) and genotypic characteristics (Table II) . Diversilab rep-PCR analysis of the 9 K. pneumo- niae isolates revealed distribution into eight clusters supportive of a polyclonal origin of these isolates in our setting (Fig. 1) . The two K. pneumoniae isolates (6a and 6b) obtained from the same patient were clustered into two different groups (Groups 1 and 2) on the basis of rep-PCR patterns (Fig. 2 ).
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Discussion
We have described the molecular epidemiology of carbapenemase resistance genes and comparison of detection methods of such mechanism in Enterobacteriaceae. Although the prevalence of CRE (1.6%) in our study is lower compared to other reported data [15] [16] , the risk factors and CRE clinical infections seen in our patients are in keeping with reported literature [17] . The most prevalent mechanism of carbapenem resistance among Enterobacteriaceae is the acquisition of carbapenemases with KPC-, NDM-, and OXA-48-type enzymes being the commonest [18] . In our study the predominant mechanism of carbapenem resistance was due to NDM enzyme with prevalence similar to data from India where 31%-55% of Enterobacteriaceae isolates were reported to be NDM producers [19] [20] . However, it is higher than the 5%-18.5% in Indian and Pakistani hospitals reported by Dortet et al. [21] . This disparity is attributable to geographical variation, isolates number studied and detection method. Within our region, sporadic reports of NDM producers have been reported in hospitals in neighbouring countries of the Arabian Gulf region and its international transfer from patients previously hospitalized in the Middle East have been reported [22] [23] .
The OXA-48 carbapenemases which were fi rst described in K. pneumoniae epidemic isolates from Turkey have now superseded VIMs and IMPs as the most common MBLs [24] . Genes for OXA-48 and related enzymes are present widely in North Africa, the Middle East and the Indian subcontinent refl ecting the high level of occurrence we have observed [25] . For three isolates (two E. coli and one E. cloacae) no carbapenemase activity was identifi ed suggesting a non-carbapenemase related resistance mechanism. The two E. coli isolates genetically demonstrated bla CTX-M1 gene with probable hyperproduction along with porin loss being responsible for apparent carbapenem resistance. However, it was quite interesting to witness E. cloacae carbapenem resistance in our study which apparently lacked any of the tested ESBLs and carbapenemase genes and we speculate that the resistance might be via porins loss or effl ux mechanism. None of the isolates was found to produce the KPC, or IMP type beta lactamase, although these enzymes have been previously documented in Saudi Arabia and Kuwait [26] [27] . Our Diversilab rep-PCR analysis of the 9 K. pneumoniae isolates revealed a polyclonal origin of these isolates. Two K. pneumoniae clones from the same patient (one harboured bla NDM-1 gene and the other bla OXA-48 gene) were resistant to amikacin, gentamicin, ciprofl oxacin and cotrimoxazole but susceptible to colistin and tigecycline. This phenomenon is rare and could be attributed to plasmid transfer.
Our evaluation of the phenotypic confi rmation test (MHT) and commercial system (MASTDISCS TM ID inhibitor combination disks) for the detection of carbapenemase production in Enterobacteriaceae showed that in keeping with previous report, the MDI disks detected all MBL positive isolates with 100% agreement with molecular genotyping data [11] . However, MDI disks are not designed to detect class D enzymes like OXA-48 and one isolate (#4) which coexpressed VIM and OXA-48 was identifi ed as MBL. Although the MHT assay reliably detects KPC and OXA-48 producers it performs poorly in the detection of MBL producers and this is refl ected in our fi ndings as none of the NDM-1 was detected by MHT [28] . Therefore for the optimal detection of CRE we recommend the use of molecular based methods. However, in resource-limited settings, a combination of the two phenotypic tests we have evaluated is a good alternative. The MASTDISCS TM will identify KPC and NDM producers, while the mod-
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ifi ed Hodge test will ensure that OXA-48 producers are detected. This will provide a cost-effective and rapid approach for the detection of carbapenemases in Enterobacteriaceae.
